Abstracts

Citation

Daniel H. Conway, M.D., Gwendolyn B. Scott, M.D., Daniel G. Muenz, B.A., Hans ML Spiegel, M.D., Ph.D., Susan Brogly, Ph.D., Katherine M. Knapp, M.D., Jeffrey Talbot, M.P.H., David E. Shapiro, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H. Prevalence of Congenital Anomalies in Infants with In Utero Exposure to Antiretrovirals: IMPAACT P1025. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

M. J. Lindstrom, D. Hoover, Newton Kumwenda, M.P.H., Ph.D., Qing Li, Lynne M. Mofenson, M.D., F.A.A.P., Mary Glenn Fowler, M.D., M.P.H., Allan W. Taylor, M. Thigpen, Taha El Tahir Taha, M.B.B.S., Ph.D., M.P.H., Susan H. Eshleman, M.D., PH.D. Comparison of Nevirapine (NVP) Resistance Among HIV-Infected Infants who Received Extended NVP Plus Zidovudine Prophylaxis vs. Extended NVP Prophylaxis Alone: the PEPI-Malawi Study. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Grant Campbell, Stephen A. Spector, M.D. 1,25-dihydroxycholecalciferol Triggers Autophagy in Human Macrophages That Inhibits Productive HIV-1 Infection. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Jorge Lujan-Zilbermann, M.D. 28 and 72 week immunogenicity of one dose vs. two doses of Quadrivalent Meningococcal Conjugate Vaccine in HIV-infected Youth. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Robert Walker, M.D., Maria Allende, M.D., Terence Fenton, Ed.D., Julie A. Patterson, B.S., George Kemble, Ph.D., Sharon Appelbaum Nachman, M.D., Tingting Yi, Patricia Alexandra Defechereux, Ph.D., Diane W. Wara, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Myron Levin, M.D. Anti-Influenza Serum and Mucosal Antibody Responses After Administration of LIve Attenuated or Inactivated Influenza Vaccines to HIV-Infected Children. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Patricia M. Flynn, M.D., M.S., Sharon Appelbaum Nachman, M.D., Stephen A. Spector, M.D., Coleen K. Cunningham, M.D., Adriana Weinberg, M.D., Robert F. Pass, M.D., Petronella Muresan, M.S., Wende Levy, R.N., M.S., George K. Siberry, M.D., M.P.H., Edward Handelsman, M.D. 2009 Influenza A (H1N1) Immunization in HIV-1 Perinatally Infected Children and Youth. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

G. M. Ellis, Andrew Koth, Tatyana Marushchak, Louis Vaz, Ingrid A. Beck, M.S., Lisa M. Frenkel, M.D. Simultaneous Detection of Human Immunodeficiency Virus Type-1 Drug Resistant Minority Genotypes by a Multiplex Oligonucleotide Ligation Assay. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Pharmacokinetic (PK), Safety and Efficacy Data on Cohort IIA; youth aged 6-11 from IMPAACT P1066: A Phase I/II Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Use of a high-resolution melting (HRM) assay to evaluate HIV gag region diversity in HIV-Infected adults with different stages of HIV infection. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

28- and 72-week immunogenicity of one dose vs. two doses of Quadrivalent Meningococcal Conjugate Vaccine in HIV-infected Youth. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.